Rothschild Investment LLC Harmony Biosciences Holdings, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 45 shares of HRMY stock, worth $1,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 25
80.0%
Holding current value
$1,326
Previous $860,000
73.72%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
262Shares Held
47MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$195 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$172 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$139 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$67.2 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$46.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.74B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...